Rosenblum Mark J (CIK 1329154) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-11-20). Recent activity: Buy SLRX (20,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-20 | Salarius Pharmaceuticals, Inc. (SLRX) | Exec VP Finance, CFO | Buy | 20,000 | $16,000 |
Source: SEC Form 4 filings · as of 2025-11-20